Re: Thoughts on ZCC
in response to
by
posted on
Sep 17, 2021 02:50PM
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
I don't disagree with a lot of the criticism. It can be difficult to distinguish between reality and wishful thinking.